Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Human Colon Mucosal Biofilms and Murine Host Communicate via Altered mRNA and microRNA Expression during Cancer.

Tomkovich S, Gharaibeh RZ, Dejea CM, Pope JL, Jiang J, Winglee K, Gauthier J, Newsome RC, Yang Y, Fodor AA, Schmittgen TD, Sears CL, Jobin C.

mSystems. 2020 Jan 14;5(1). pii: e00451-19. doi: 10.1128/mSystems.00451-19.

2.

Gut Microbiota Composition and Blood Pressure.

Sun S, Lulla A, Sioda M, Winglee K, Wu MC, Jacobs DR Jr, Shikany JM, Lloyd-Jones DM, Launer LJ, Fodor AA, Meyer KA.

Hypertension. 2019 May;73(5):998-1006. doi: 10.1161/HYPERTENSIONAHA.118.12109.

PMID:
30905192
3.

Human colon mucosal biofilms from healthy or colon cancer hosts are carcinogenic.

Tomkovich S, Dejea CM, Winglee K, Drewes JL, Chung L, Housseau F, Pope JL, Gauthier J, Sun X, Mühlbauer M, Liu X, Fathi P, Anders RA, Besharati S, Perez-Chanona E, Yang Y, Ding H, Wu X, Wu S, White JR, Gharaibeh RZ, Fodor AA, Wang H, Pardoll DM, Jobin C, Sears CL.

J Clin Invest. 2019 Mar 11;130:1699-1712. doi: 10.1172/JCI124196. eCollection 2019 Mar 11.

4.

Whole Genome Sequencing detects Inter-Facility Transmission of Carbapenem-resistant Klebsiella pneumoniae.

Spencer MD, Winglee K, Passaretti C, Earl AM, Manson AL, Mulder HP, Sautter RL, Fodor AA.

J Infect. 2019 Mar;78(3):187-199. doi: 10.1016/j.jinf.2018.11.003. Epub 2018 Nov 29.

5.

Initial microbial community of the neonatal stomach immediately after birth.

Bajorek S, Parker L, Li N, Winglee K, Weaver M, Johnson J, Sioda M, Gauthier J, Lemas DJ, Jobin C, Lorca G, Neu J, Fodor AA.

Gut Microbes. 2019;10(3):289-297. doi: 10.1080/19490976.2018.1520578. Epub 2018 Nov 7.

6.

Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.

Thomas RM, Gharaibeh RZ, Gauthier J, Beveridge M, Pope JL, Guijarro MV, Yu Q, He Z, Ohland C, Newsome R, Trevino J, Hughes SJ, Reinhard M, Winglee K, Fodor AA, Zajac-Kaye M, Jobin C.

Carcinogenesis. 2018 Jul 30;39(8):1068-1078. doi: 10.1093/carcin/bgy073.

7.

An Aberrant Microbiota is not Strongly Associated with Incidental Colonic Diverticulosis.

Jones RB, Fodor AA, Peery AF, Tsilimigras MCB, Winglee K, McCoy A, Sioda M, Sandler RS, Keku TO.

Sci Rep. 2018 Mar 21;8(1):4951. doi: 10.1038/s41598-018-23023-z.

8.

Microbiota-Derived Metabolic Factors Reduce Campylobacteriosis in Mice.

Sun X, Winglee K, Gharaibeh RZ, Gauthier J, He Z, Tripathi P, Avram D, Bruner S, Fodor A, Jobin C.

Gastroenterology. 2018 May;154(6):1751-1763.e2. doi: 10.1053/j.gastro.2018.01.042. Epub 2018 Feb 1.

9.

Recent urbanization in China is correlated with a Westernized microbiome encoding increased virulence and antibiotic resistance genes.

Winglee K, Howard AG, Sha W, Gharaibeh RZ, Liu J, Jin D, Fodor AA, Gordon-Larsen P.

Microbiome. 2017 Sep 15;5(1):121. doi: 10.1186/s40168-017-0338-7.

10.

Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.

Gupta S, Cheung L, Pokkali S, Winglee K, Guo H, Murphy JR, Bishai WR.

J Infect Dis. 2017 Jun 15;215(12):1883-1887. doi: 10.1093/infdis/jix208.

11.

Locoregional Effects of Microbiota in a Preclinical Model of Colon Carcinogenesis.

Tomkovich S, Yang Y, Winglee K, Gauthier J, Mühlbauer M, Sun X, Mohamadzadeh M, Liu X, Martin P, Wang GP, Oswald E, Fodor AA, Jobin C.

Cancer Res. 2017 May 15;77(10):2620-2632. doi: 10.1158/0008-5472.CAN-16-3472. Epub 2017 Apr 17.

12.

Bacterial subversion of cAMP signalling inhibits cathelicidin expression, which is required for innate resistance to Mycobacterium tuberculosis.

Gupta S, Winglee K, Gallo R, Bishai WR.

J Pathol. 2017 May;242(1):52-61. doi: 10.1002/path.4878. Epub 2017 Mar 15.

13.

Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance.

Manson AL, Cohen KA, Abeel T, Desjardins CA, Armstrong DT, Barry CE 3rd, Brand J; TBResist Global Genome Consortium, Chapman SB, Cho SN, Gabrielian A, Gomez J, Jodals AM, Joloba M, Jureen P, Lee JS, Malinga L, Maiga M, Nordenberg D, Noroc E, Romancenco E, Salazar A, Ssengooba W, Velayati AA, Winglee K, Zalutskaya A, Via LE, Cassell GH, Dorman SE, Ellner J, Farnia P, Galagan JE, Rosenthal A, Crudu V, Homorodean D, Hsueh PR, Narayanan S, Pym AS, Skrahina A, Swaminathan S, Van der Walt M, Alland D, Bishai WR, Cohen T, Hoffner S, Birren BW, Earl AM.

Nat Genet. 2017 Mar;49(3):395-402. doi: 10.1038/ng.3767. Epub 2017 Jan 16.

14.

REMap: Operon map of M. tuberculosis based on RNA sequence data.

Pelly S, Winglee K, Xia FF, Stevens RL, Bishai WR, Lamichhane G.

Tuberculosis (Edinb). 2016 Jul;99:70-80. doi: 10.1016/j.tube.2016.04.010. Epub 2016 Apr 29.

15.

Whole Genome Sequencing of Mycobacterium africanum Strains from Mali Provides Insights into the Mechanisms of Geographic Restriction.

Winglee K, Manson McGuire A, Maiga M, Abeel T, Shea T, Desjardins CA, Diarra B, Baya B, Sanogo M, Diallo S, Earl AM, Bishai WR.

PLoS Negl Trop Dis. 2016 Jan 11;10(1):e0004332. doi: 10.1371/journal.pntd.0004332. eCollection 2016 Jan.

16.

Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.

Kubler A, Larsson C, Luna B, Andrade BB, Amaral EP, Urbanowski M, Orandle M, Bock K, Ammerman NC, Cheung LS, Winglee K, Halushka M, Park JK, Sher A, Friedland JS, Elkington PT, Bishai WR.

J Infect Dis. 2016 Feb 15;213(4):618-27. doi: 10.1093/infdis/jiv458. Epub 2015 Sep 27.

17.

Mutation of Rv2887, a marR-like gene, confers Mycobacterium tuberculosis resistance to an imidazopyridine-based agent.

Winglee K, Lun S, Pieroni M, Kozikowski A, Bishai W.

Antimicrob Agents Chemother. 2015 Nov;59(11):6873-81. doi: 10.1128/AAC.01341-15. Epub 2015 Aug 24.

18.

Intrinsic association between diet and the gut microbiome: current evidence.

Winglee K, Fodor AA.

Nutr Diet Suppl. 2015;7:69-76. doi: 10.2147/NDS.S62362. Epub 2015 Oct 7.

19.

Synthetic lethality reveals mechanisms of Mycobacterium tuberculosis resistance to β-lactams.

Lun S, Miranda D, Kubler A, Guo H, Maiga MC, Winglee K, Pelly S, Bishai WR.

mBio. 2014 Sep 16;5(5):e01767-14. doi: 10.1128/mBio.01767-14.

20.

Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation.

Kübler A, Luna B, Larsson C, Ammerman NC, Andrade BB, Orandle M, Bock KW, Xu Z, Bagci U, Mollura DJ, Marshall J, Burns J, Winglee K, Ahidjo BA, Cheung LS, Klunk M, Jain SK, Kumar NP, Babu S, Sher A, Friedland JS, Elkington PT, Bishai WR.

J Pathol. 2015 Feb;235(3):431-44. doi: 10.1002/path.4432. Epub 2014 Oct 6.

21.

Aerosol Mycobacterium tuberculosis infection causes rapid loss of diversity in gut microbiota.

Winglee K, Eloe-Fadrosh E, Gupta S, Guo H, Fraser C, Bishai W.

PLoS One. 2014 May 12;9(5):e97048. doi: 10.1371/journal.pone.0097048. eCollection 2014.

22.

Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis.

Gupta S, Cohen KA, Winglee K, Maiga M, Diarra B, Bishai WR.

Antimicrob Agents Chemother. 2014;58(1):574-6. doi: 10.1128/AAC.01462-13. Epub 2013 Oct 14.

23.

Evaluation of the pathogenesis and treatment of Mycobacterium marinum infection in zebrafish.

Takaki K, Davis JM, Winglee K, Ramakrishnan L.

Nat Protoc. 2013 Jun;8(6):1114-24. doi: 10.1038/nprot.2013.068. Epub 2013 May 16.

24.

Risk of tuberculosis reactivation with tofacitinib (CP-690550).

Maiga M, Lun S, Guo H, Winglee K, Ammerman NC, Bishai WR.

J Infect Dis. 2012 Jun;205(11):1705-8. doi: 10.1093/infdis/jis269. Epub 2012 Apr 3. Erratum in: J Infect Dis. 2015 Jul 15;212(2):338. Dosage error in article text.

25.

Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L.

Cell. 2011 Apr 1;145(1):39-53. doi: 10.1016/j.cell.2011.02.022. Epub 2011 Mar 3. Erratum in: Cell. 2011 Apr 1;145(1):159.

Supplemental Content

Loading ...
Support Center